Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor

References

• Barnes L, Eveson JW, Reichart P, Sidransky D. Odontogenic tumours (Chapter 6). In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds). World Health Organization classification of tumors. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p 306–7.
   Google Scholar
• Pinheiro J, Freitas V, Moretti A, Jorge A, Jaeger R. Local invasiveness of Ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 2004;45:65–72.
   PubMed Web of Science ®Google Scholar
• Regezi JA. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol 2002;15:331–41.
   PubMed Web of Science ®Google Scholar
• Shear M. Odontogenic keratocyst and dentigerous cyst In: Shear M ed. In cysts of the oral regions. 3rd ed. Oxford: Butterworth-Heinemann; 1992.
   Google Scholar
• Bologna-Molina R, Mosqueda-Taylor A, Lopez- Corella E, Almeida OP, Carrasco-Daza D, Garcia-Vazquez F, Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008;44:805–11.
   PubMed Web of Science ®Google Scholar
• Gadbail AR, Chaudhary M, Patil S, Gawande M. Actual Proliferating Index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis 2009;15:490–8.
   PubMed Web of Science ®Google Scholar
• Meer S, Galpin JS, Altini M, Coleman H, Ali H. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:213–21.
   PubMed Web of Science ®Google Scholar
• Migaldi M, Sartori G, Rossi G, Cittadini A, Sgambato A. Tumor cell proliferation and microsatellite alterations in human ameloblastoma. Oral Oncol 2008;44:50–60.
   PubMed Web of Science ®Google Scholar
• Ong'uti MN, Cruchley AT, Howells GL, Williams DM. Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya. Int J Oral Maxillofac Surg 1997;26:376–9.
   PubMed Web of Science ®Google Scholar
• Piatelli A, Fioroni M, Santinelli A, Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 1998;34:408–12.
   PubMed Web of Science ®Google Scholar
• Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki67 in ameloblastoma. Oral Oncol 2001;37:193–8.
   PubMed Web of Science ®Google Scholar
• Thosaporn W, Iamaroon A, Pongsiriwet S, Ng KH. A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma. Oral Dis 2004;10:22–6.
   PubMed Web of Science ®Google Scholar
• Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions: an immunohistochemical study. J Oral Pathol Med 1995;24:393–7.
   PubMed Web of Science ®Google Scholar
• Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2–11.
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N. Neoplasia (Chapter 6). In: Kumar V, Abbas AK, Fausto N eds. : Robbins and Cotran pathologic basis of diseases. 7th ed Philadelphia, PA: Saunders; 2004. p 302–3.
   Google Scholar
• Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000;29:413–25.
   PubMed Web of Science ®Google Scholar
• Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 1998;184:360–8.
   PubMed Web of Science ®Google Scholar
• Pillai G, Roberts H, Gatter K, Pezzella F. p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems. Histopathology 2003;42:83–7.
   PubMed Web of Science ®Google Scholar
• Gardner DG. Some current concepts on the pathology of ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:660–9.
   PubMed Web of Science ®Google Scholar
• Kurokava H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Immunohistochemical study of Syndecan 2 down regulation and the expression of p53 protein or Ki-67 antigen in oral Leukoplakia with or withought dysplasia. J Oral Pathol Med 2003;32:513–21.
   PubMed Web of Science ®Google Scholar
• Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 1997;26:419–25.
   PubMed Web of Science ®Google Scholar
• Skomedal H, Kristensen GB, Abeler VM, Børresen-Dale AL, Tropé C, Holm R. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas. J Pathol 1997;181:158–65.
   PubMed Web of Science ®Google Scholar
• Shibata T, Nakata D, Chiba I, Yamashita T, Abiko Y, Tada M, Detection of TP53 mutation in ameloblastoma by the use of a yeast functional assay. J Oral Pathol Med 2002;31:534–8.
   PubMed Web of Science ®Google Scholar
• Kumamoto H, Izutsu T, Ohki K, Takahashi N, Ooya K. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas. J Oral Pathol Med 2004;33:292–9.
   PubMed Web of Science ®Google Scholar
• Nodit L, Barnes L, Childers E, Finkelstein S, Swalsky P, Hunt J. Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol 2004;17:1062–7.
   PubMed Web of Science ®Google Scholar
• el-Sissy NA. Immunohistochemical detection of p53 protein in ameloblastoma types. East Mediterr Health J 1999;5:478–89.
   PubMedGoogle Scholar
• Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, p53 mutations, ras mutations and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090–6.
   PubMed Web of Science ®Google Scholar
• Vojtesek B, Lane DP. Regulation of p53 protein expression in human breast cancer cell lines. J Cell Sci 1993;105:607–12.
   PubMed Web of Science ®Google Scholar
• Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 1996;25:245–55.
   PubMed Web of Science ®Google Scholar
• Chirapathomsakul D, Sastravaha P, Jansisyanont P. A review of odontogenic keratocysts and the behavior of recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:5–9.
   PubMed Web of Science ®Google Scholar
• Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol 2002;38:323–31.
   PubMed Web of Science ®Google Scholar
• Agaram NP, Collins B, Barnes L, Lomago D, Aldeeb D, Swalsky P, Molecular analysis to demonstrate that odontogenic keratocyst are neoplastic. Arch Pathol Lab Med 2004 1;l28:313–7.
   Google Scholar
• Henley J, Summerlin DJ, Tomich C, Zhang S, Cheng L. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histpathology 2005;47:582–6.
   PubMed Web of Science ®Google Scholar
• Malcic A, Jukic S, Anic I, Pavelic B, Kruslin B, Pavelic K, Alterations of FHIT and P53 genes in Keratocystic odontogenic tumour, dentigerous and radicular cyst. J Oral Pathol Med 2008;37:294–301.
   PubMed Web of Science ®Google Scholar
• Kuroyanagi N, Machida J, Sakuma H, Miyabe S, Hashimoto O, Yokoi M, p53 mutations in Keratocystic odontogenic tumour. Oral Surgery 2009;2:64–70.
   Google Scholar
• Dowell SP, Ogden GR. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. J Oral Pathol Med 1996;25:60–4.
   PubMed Web of Science ®Google Scholar
• Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? Revisited. J Pathol 1994;72:1–4.
   Google Scholar
• Marine J-C, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 2006;13:927–34.
   PubMed Web of Science ®Google Scholar
• Wu X, Bayle JH, Olson D, Levine AJ. The p53- mdm-2 autoregulatory feedback loop. Genes Dev 1993;7:1126–32.
   PubMed Web of Science ®Google Scholar